Skin Cancer Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceParadoxically important - sun avoidance leads to deficiency; some evidence for anti-cancer effects; supports immune function
Reduces new skin cancer development in high-risk individuals; supports DNA repair
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsAnti-inflammatory; may reduce UV-induced skin damage; supports overall health during treatment
Supporting Studies (1)
Antioxidant; may provide some photoprotection; laboratory studies show anti-skin cancer effects
Supporting Studies (1)
Antioxidant; mixed evidence for skin cancer prevention; may support immune function
Supporting Studies (1)
Anti-inflammatory; laboratory studies suggest effects on skin cancer cells
Supporting Studies (1)
Antioxidant; may help protect skin from oxidative damage; topical use studied
Supporting Studies (1)
Antioxidant; supports collagen and skin healing; topical formulations studied
Supporting Studies (1)
Antioxidant; may provide mild photoprotection; avoid in smokers (lung cancer risk)
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Skin cancer is the most common type of cancer, with three main types: basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. BCC and SCC are non-melanoma skin cancers and are usually curable. Melanoma is more dangerous but also treatable if caught early.
TYPES OF SKIN CANCER:
CRITICAL: Skin cancer requires medical treatment. This protocol is SUPPORTIVE ONLY for overall skin health and cancer recovery.
TREATMENT depends on type and stage:
PREVENTION is key:
THE VITAMIN D PARADOX:
Sun exposure causes skin cancer, but we need sun for vitamin D. Solution: supplement vitamin D while protecting skin from excess sun.
* Nicotinamide (vitamin B3) has the strongest evidence - it reduced new skin cancers by 23% in high-risk individuals in the ONTRAC trial.
* Vitamin D should be supplemented since sun avoidance is necessary for prevention.
Expected timeline: Prevention is ongoing. During and after treatment, supplements support general health and healing.
Clinical Perspective
Skin Cancer: Three main types - basal cell carcinoma (BCC, most common, locally destructive, rarely metastasizes), squamous cell carcinoma (SCC, second most common, can metastasize), melanoma (most deadly, metastatic potential high). Risk factors: UV exposure (cumulative for BCC/SCC, intermittent intense for melanoma), fair skin, family history, immunosuppression, dysplastic nevi. Screening: full skin exams; ABCDE criteria for melanoma.
CRITICAL: Treatment is surgical (excision, Mohs), radiation, or systemic therapy (immunotherapy, targeted therapy for melanoma). Prevention: sunscreen, protective clothing, sun avoidance. Supplements are supportive; nicotinamide has evidence for prevention in high-risk. Vitamin D important as sun avoidance needed.
* Vitamin D (B-grade): Sun avoidance causes deficiency; some anti-cancer data. Systematic review: (PMID: 28750270). Meta-analysis melanoma: (PMID: 26096827). 2000-4000 IU daily.
* Nicotinamide (A-grade): DNA repair; prevention in high-risk. ONTRAC trial: (PMID: 26488693). 500mg BID. 23% reduction in new non-melanoma skin cancers.
* Omega-3 Fatty Acids (C-grade): Anti-inflammatory; UV protection. Systematic review: (PMID: 27840029). 2-3g EPA+DHA daily.
* Green Tea (EGCG) (C-grade): Photoprotection. Review: (PMID: 26440377). 250-500mg daily. Topical also studied.
* Selenium (C-grade): Mixed evidence. Systematic review: (PMID: 28558777). 100-200mcg daily.
* Curcumin (C-grade): Lab studies only. Review: (PMID: 25282711). 500-1500mg daily.
* Vitamin E (C-grade): Antioxidant. Review: (PMID: 27918887). 400 IU daily.
* Vitamin C (C-grade): Skin health; healing. Review: (PMID: 23075608). 500-1000mg daily.
* Beta-Carotene (C-grade): Mild photoprotection. Systematic review: (PMID: 26096827). 15-25mg daily. Avoid in smokers.
Assessment targets: Skin examination (new lesions, changes), staging if diagnosed, vitamin D level, treatment response monitoring.
Protocol notes: Sunscreen: SPF 30+, broad-spectrum, reapply every 2 hours and after swimming/sweating; use year-round. Vitamin D: virtually all dermatologists recommend supplementation given necessary sun avoidance. Nicotinamide: different from niacin; doesn't cause flushing; specific to prevention in high-risk (multiple prior BCC/SCC). High-risk populations: organ transplant recipients (50-250x increased risk), immunosuppression - aggressive surveillance and prevention. Actinic keratoses: precancerous; treat to prevent progression to SCC. Melanoma surveillance: regular imaging if history; PET/CT for advanced. Immunotherapy: checkpoint inhibitors revolutionized advanced melanoma treatment. Targeted therapy: BRAF/MEK inhibitors for BRAF-mutant melanoma. Wound healing: post-surgical care important; vitamin C, zinc support healing. Indoor tanning: strong carcinogen; avoid completely. PUVA therapy: used for psoriasis; increases skin cancer risk - monitor closely.